New England Capital Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.8K Sell
1,225
-180
-13% -$14.5K 0.02% 92
2026
Q1
$122K Buy
1,405
+2
+0.1% +$192 0.03% 82
2025
Q4
$135K Buy
1,403
+101
+8% +$9.81K 0.05% 80
2025
Q3
$124K Buy
1,302
+2
+0.2% +$184 0.05% 80
2025
Q2
$113K Buy
1,300
+1
+0.1% +$85 0.05% 76
2025
Q1
$117K Buy
1,299
+2
+0.2% +$179 0.06% 74
2024
Q4
$104K Sell
1,297
-6
-0.5% -$519 0.05% 78
2024
Q3
$117K Buy
1,303
+2
+0.2% +$168 0.06% 68
2024
Q2
$102K Buy
1,301
+1
+0.1% +$82 0.06% 74
2024
Q1
$113K Buy
1,300
+2
+0.2% +$171 0.06% 67
2023
Q4
$107K Sell
1,298
-166
-11% -$12.7K 0.06% 73
2023
Q3
$115K Buy
1,464
+2
+0.1% +$167 0.08% 67
2023
Q2
$129K Buy
1,462
+1
+0.1% +$86 0.09% 62
2023
Q1
$118K Hold
1,461
0.08% 67
2022
Q4
$118K Buy
+1,461
New +$118K 0.08% 69

Other funds holding MDT

New England Capital Financial Advisors's MDT Position: Q2 2026 in Review

New England Capital Financial Advisors reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $14.5K and leaving 1,225 shares worth $95.8K. The position accounts for 0.02% of the portfolio, ranked #92.

New England Capital Financial Advisors first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $135K in Q4 2025. 1,560 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • New England Capital Financial Advisors held 1,225 shares of Medtronic worth $95.8K as of Q2 2026.
  • New England Capital Financial Advisors sold 180 Medtronic shares in Q2 2026, an estimated $14.5K.
  • Medtronic made up 0.02% of New England Capital Financial Advisors's portfolio in Q2 2026, its #92 holding.
  • New England Capital Financial Advisors first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Medtronic position peaked at $135K in Q4 2025.
  • 1,560 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.